American Oriental Bioengineering, Inc. (AOB)
4.13USD
9 Feb 2010
$0.05 (+1.23%)
$4.13
--
$4.16
$4.04
769,695
1,139,053
$6.38
$3.29
AOB
About
Overall
| Beta: | 1.71 |
| Market Cap (Mil.): | $323.47 |
| Shares Outstanding (Mil.): | 78.32 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| AOB | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 8.51 | 1.96 | 3.76 |
| EPS (TTM): | -31.86 | -- | -- |
| ROI: | 7.66 | 0.92 | 2.30 |
| ROE: | 11.76 | 1.27 | 2.82 |
American Oriental Bioengineering Q3 results
AMERICAN ORIENTAL BIOENGINEERING INC : * Third quarter earnings per share $0.16 * Forecasts fiscal year 2007 earnings per share about $0.60 * Third quarter revenue rose 60.7 percent to $43.5 million * Forecasts fiscal year 2007 revenue about $160 million * Reuters Estimates third quarter earnings per share view $0.15, revenue view $41.75 million * Reuters Estimates fiscal year 2007 earnings per share view $0.60, revenue view $158.09 million
American Oriental plans to buy plant-based healthcare company
Aug 8 (Reuters) - American Oriental Bioengineering Inc. said it plans to acquire Guangxi Boke Pharmaceutical Co. Ltd., a privately owned plant-based healthcare company in China, for about $40 million in cash.
TABLE-American Oriental Q2 earnings rise
AMERICAN ORIENTAL BIOENGINEERING INC. (in $) Latest Yr-ago qtr EPS (diluted) 0.15 0.09 Net (million) 9.7 5.8 Revenue (million) 33.9 22.8 Reuters Estimates: EPS $0.14, revenue $33.0 million (Reporting by Savitha Kalyanaraman in Bangalore)
American Oriental offering priced at $8.50/shr
June 28 (Reuters) - Pharmaceutical company American Oriental Bioengineering Inc. said its offering of 8.5 million shares has been priced at $8.50 a share.
American Oriental Bioengineering to offer 8 mln shares
June 27 (Reuters) - Pharmaceutical company American Oriental Bioengineering Inc. said in a regulatory filing that it will offer 8 million shares and selling stockholders will sell 500,000 shares.
American Oriental to buy Chinese firm for about $30 mln
June 13 (Reuters) - Pharmaceutical and nutraceutical company American Oriental Bioengineering Inc. signed a letter of intent to buy privately owned Changchun Xinan Pharmaceutical Group Co. Ltd. for nearly $30 million.
American Oriental to offer 13 mln shares
June 4 (Reuters) - American Oriental Bioengineering Inc. said it is making a public offer of 13 million common shares to raise about $130.3 million in net proceeds.
Competitors
| Price | Change | |
|---|---|---|
| Harbin Pharmaceutical Group Co., Ltd. (600664.SS) | ¥17.42 | +0.43 |
| Tianjin Zhongxin Pharmaceutical Group Co (600329.SS) | ¥24.88 | +0.17 |
| Tianjin Zhongxin Pharmaceutical Group Co (TIANbi.SI) | $0.34 | 0.00 |
| Harbin High-Tech (Group) Co.,Ltd (600095.SS) | ¥6.61 | +0.02 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
